Motilent
About Motilent
Motilent is a leading healthcare AI company dedicated to transforming the understanding and management of digestive diseases through advanced medical image analysis. Their core mission is to enhance patient care by supporting cutting-edge research, advancing clinical trials, and ultimately changing clinical practice in gastroenterology. The company develops innovative medical imaging and collaborative technology platforms, enabling researchers and clinicians to gain deeper insights into the complexities of the gastrointestinal (GI) tract.
At the heart of Motilent’s offerings is GIQuant, a sophisticated post-processing software that quantitatively measures and tracks intestinal motility using standard magnetic resonance imaging (MRI) scans. This objective assessment of bowel movement is crucial for understanding disease progression and evaluating treatment response, particularly in conditions such as Crohn’s disease, where altered motility is often indicative of active inflammation. GIQuant holds both FDA Class II clearance and CE Mark Class IIa, making it suitable for use in both adult and pediatric populations. Complementing GIQuant, Motilent also provides EntrolyticsMD, a comprehensive imaging platform optimized for various modalities including MRI, CT, and intestinal ultrasound. This platform integrates streamlined data management with advanced processing tools, incorporating AI-powered features and GIQuant to facilitate high-quality research and clinical assessment.
Motilent’s technology is designed to deliver data-driven insights that inform therapeutic decisions, allowing physicians to more effectively monitor treatment response and potentially identify ineffective therapies sooner. This capability aims to accelerate patient treatment journeys and improve clinical outcomes. The company is committed to translating its advanced technological innovations into practical clinical applications and actively engages in groundbreaking research collaborations with international partners, with a particular emphasis on non-invasive gastroenterology technologies.
What Physicians Need to Know
For physicians, Motilent's tools offer a significant advantage in managing digestive diseases. GIQuant provides objective, quantitative data on intestinal motility from MRI, enabling earlier and more informed decisions on treatment response, especially in Crohn's disease, where visual assessment can be subjective. The EntrolyticsMD platform acts as a specialized 'PACS for the gut,' centralizing multi-modality imaging data (MRI, ultrasound, endoscopy, CT) into a single, accessible, and collaborative environment. This streamlines workflow, enhances diagnostic capabilities, and supports better patient communication through advanced visualizations like vEUA. By leveraging these AI-powered insights, clinicians can move patients off ineffective therapies faster, optimize treatment pathways, and improve overall patient outcomes in complex GI conditions. The non-invasive nature of their primary assessment methods (MRI, ultrasound) also reduces patient burden compared to more invasive diagnostic tools. Consider how integrating these quantitative metrics can enhance your current monitoring protocols and multidisciplinary team discussions.
Motilent's GIQuant is integrated within a DICOM compliant workflow server and its output can be viewed in standard 'off the shelf' DICOM viewers. EntrolyticsMD supports automatic data pushes from PACS and is designed to host and integrate with both proprietary and third-party AI image analysis tools. They have also partnered with Nuance AI solutions for deployment in the U.S. healthcare market. Bridge securely connects directly to ultrasound systems for data capture. The platform is built on ISO-27001 infrastructure with HIPAA and GDPR compliance, ensuring secure and compliant data handling.
What the Web Says
Motilent is a UK-based medical imaging company specializing in quantifying gut motility using MRI. Their primary product, GIQuant, is an AI-powered software designed to provide objective and non-invasive measurements of gastrointestinal function. While specific product reviews are limited on major platforms, the company is generally viewed positively within the healthcare IT and academic communities for its innovative approach to diagnosing and monitoring GI disorders.
Overall: PositiveStrengths
- Innovative technology for gut motility assessment (GIQuant)
- Addresses an unmet need in gastroenterology diagnostics
- Non-invasive and objective measurement using MRI
- Potential to improve diagnosis and treatment monitoring for GI conditions
- Strong scientific and academic backing
- Focus on a specialized and impactful area of medical imaging
Limitations
- Limited public product reviews on mainstream platforms (G2, Capterra)
- Specific employer reviews (Glassdoor) are scarce or non-existent
- Relatively niche market, potentially slower adoption compared to broader solutions
- Reliance on MRI infrastructure may limit accessibility in some settings
- Newer technology, so long-term clinical impact is still being established
- Pricing and implementation details not readily available
Based on reviews from: Motilent Official Website, Healthcare IT News articles (general mentions), Academic publications referencing Motilent's technology, Industry reports on medical imaging and AI in healthcare, Limited general web searches for reviews (G2, Glassdoor, Capterra, Reddit - no specific results found)
Last updated: 2026-07-21
Videos
News, demos, and interviews about Motilent.
Videos load interactively. If none appear, search YouTube for Motilent →
Press & Coverage
Frequently Asked Questions
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]